School of Medicine
Showing 41-50 of 54 Results
-
Helge Raeder MD PhD
Visiting Professor, Genetics
BioHelge Ræder is a Full Professor at the Faculty of Medicine, University of Bergen (UiB), Norway and a Senior Consultant in Pediatric Endocrinology at Haukeland University Hospital, Bergen, Norway. With a background in cellular biology and diabetes research, he has significantly contributed to understanding diabetes through stem cell research. He has been a visiting scholar at Joslin Diabetes Center, Harvard Medical School with C. Ronald Kahn (2005-2006) and with Rohit N Kulkarni (2010-2011). As the Vice Dean of Innovation at UiB (2017-2024), he has spearheaded the establishment of ecosystems that catalyze breakthrough innovations, including a new Medical Innovation Centre. His research aims to unravel the biology of diabetes and endocrine disorders, focusing on the interplay between genetics, proteomics, and stem cell biology. Dr. Ræder's work has resulted in publications in high-impact journals including Nature, Nature Genetics, Nature Metabolism, Diabetes, Journal of Bone and Mineral Research and Nature Reviews Endocrinology. He has been recognized with several awards, including the Young Investigator’s Award from the International Society for Pediatric and Adolescent Diabetes. He has been an invited speaker at the IPITA-JDRF-HSCI Key opinion leader´s meeting on stem cell-derived beta cells at Harvard Medical School. Currently, he is a visiting professor at Stanford University, contributing to precision health research focusing on developing endocrine digital twins at Prof. Michael Snyder's Lab.
-
Julien Sage
Elaine and John Chambers Professor of Pediatric Cancer and Professor of Genetics
Current Research and Scholarly InterestsWe investigate the mechanisms by which normal cells become tumor cells, and we combine genetics, genomics, and proteomics approaches to investigate the differences between the proliferative response in response to injury and the hyperproliferative phenotype of cancer cells and to identify novel therapeutic targets in cancer cells.
-
Serena Sanulli
Assistant Professor of Genetics
Current Research and Scholarly InterestsWe study the organizing principles of the genome and how these principles regulate cell identity and developmental switches. We combine Biochemistry and Biophysical methods such as NMR and Hydrogen-Deuterium Exchange-MS with Cell Biology, and Genetics to explore genome organization across length and time scales and understand how cells leverage the diverse biophysical properties of chromatin to regulate genome function.
-
Gavin Sherlock
Professor of Genetics
Current Research and Scholarly InterestsEvolution and the adaptive landscape using yeast as a model; Defining yeast transcriptomes; chromosomal evolution in hybrid yeast species
-
Arend Sidow
Professor of Pathology and of Genetics
Current Research and Scholarly InterestsWe have a highly collaborative research program in the evolutionary genomics of cancer. We apply well-established principles of phylogenetics to cancer evolution on the basis of whole genome sequencing and functional genomics data of multiple tumor samples from the same patient. Introductions to our work and the concepts we apply are best found in the Newburger et al paper in Genome Research and the Sidow and Spies review in TIGS.
More information can be found here: http://www.sidowlab.org -
Michael Snyder, Ph.D.
Stanford W. Ascherman Professor of Genetics
Current Research and Scholarly InterestsOur laboratory use different omics approaches to study a) regulatory networks, b) intra- and inter-species variation which differs primarily at the level of regulatory information c) human health and disease. For the later we have established integrated Personal Omics Profiling (iPOP), an analysis that combines longitudinal analyses of genomic, transcriptomic, proteomic, metabolomic, DNA methylation, microbiome and autoantibody profiles to monitor healthy and disease states
-
Lars Steinmetz
Dieter Schwarz Foundation Endowed Professor
Current Research and Scholarly InterestsThe Steinmetz lab develops genomic technologies to study the genetic basis of complex phenotypes, the mechanisms of gene regulation, and the molecular systems underpinning disease. We’re leveraging biological insights across scales and organisms to predict, diagnose, treat and ultimately prevent disease.
-
Hua Tang
Professor of Genetics and, by courtesy, of Statistics
Current Research and Scholarly InterestsDevelop statistical and computational methods for population genomics analyses; modeling human evolutionary history; genetic association studies in admixed populations.
-
Alice Ting
Professor of Genetics, of Biology and, by courtesy, of Chemistry
On Leave from 09/22/2025 To 06/10/2026Current Research and Scholarly InterestsWe develop chemogenetic and optogenetic technologies for probing and manipulating protein networks, cellular RNA, and the function of mitochondria and the mammalian brain. Our technologies draw from protein engineering, directed evolution, computational design, chemical biology, organic synthesis, microscopy, and genomics.
-
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.